AEON Biopharma, Inc. (AEON)
0.1603
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:32
AEON Biopharma Total Liabilities (Quarterly) : 21.27M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.27M |
| March 31, 2026 | 25.38M |
| December 31, 2025 | 60.59M |
| September 30, 2025 | 28.61M |
| June 30, 2025 | 27.51M |
| March 31, 2025 | 25.12M |
| December 31, 2024 | 31.71M |
| September 30, 2024 | 36.09M |
| June 30, 2024 | 33.68M |
| March 31, 2024 | 201.41M |
| December 31, 2023 | 159.89M |
| September 30, 2023 | 146.02M |
| Date | Value |
|---|---|
| June 30, 2023 | 12.05M |
| March 31, 2023 | 7.942M |
| December 31, 2022 | 143.24M |
| September 30, 2022 | 11.97M |
| June 30, 2022 | 12.80M |
| March 31, 2022 | 14.80M |
| December 31, 2021 | 17.88M |
| September 30, 2021 | 18.38M |
| June 30, 2021 | 24.45M |
| March 31, 2021 | 20.99M |
| December 31, 2020 | 0.0596M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.91M |
| Shareholders Equity (Quarterly) | -15.36M |
| Debt to Equity Ratio | -0.1807 |
| Current Ratio | 0.5439 |
| Net Debt Paydown Yield | 12.50% |